www.dbv-technologies.com Open in urlscan Pro
192.124.249.163  Public Scan

Form analysis
2 forms found in the DOM

GET https://www.dbv-technologies.com/

<form class="mk-header-searchform" method="get" id="mk-header-searchform" action="https://www.dbv-technologies.com/">
  <span>
    <input type="text" class="text-input on-close-state" value="" name="s" id="s" placeholder="Search">
    <i class="mk-searchform-icon"><svg class="mk-svg-icon" data-name="mk-icon-search" data-cacheid="icon-6334973eaa910" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 1664 1792"><path d="M1152 832q0-185-131.5-316.5t-316.5-131.5-316.5 131.5-131.5 316.5 131.5 316.5 316.5 131.5 316.5-131.5 131.5-316.5zm512 832q0 52-38 90t-90 38q-54 0-90-38l-343-342q-179 124-399 124-143 0-273.5-55.5t-225-150-150-225-55.5-273.5 55.5-273.5 150-225 225-150 273.5-55.5 273.5 55.5 225 150 150 225 55.5 273.5q0 220-124 399l343 343q37 37 37 90z"></path></svg><input value="" type="submit" class="header-search-btn"></i>
  </span>
</form>

GET https://www.dbv-technologies.com/

<form class="responsive-searchform" method="get" action="https://www.dbv-technologies.com/">
  <input type="text" class="text-input" value="" name="s" id="s" placeholder="Search..">
  <i><input value="" type="submit"><svg class="mk-svg-icon" data-name="mk-icon-search" data-cacheid="icon-6334973ecbc6b" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 1664 1792"><path d="M1152 832q0-185-131.5-316.5t-316.5-131.5-316.5 131.5-131.5 316.5 131.5 316.5 316.5 131.5 316.5-131.5 131.5-316.5zm512 832q0 52-38 90t-90 38q-54 0-90-38l-343-342q-179 124-399 124-143 0-273.5-55.5t-225-150-150-225-55.5-273.5 55.5-273.5 150-225 225-150 273.5-55.5 273.5 55.5 225 150 150 225 55.5 273.5q0 220-124 399l343 343q37 37 37 90z"></path></svg></i>
</form>

Text Content

OUR SCIENCE


THE VIASKIN™ PATCH IS OUR NOVEL APPROACH TO EPIT™

Learn more

OUR SCIENCE


THE VIASKIN™ PATCH IS OUR NOVEL APPROACH TO EPIT™

Learn More


Languages
 * Français
 * English

 * Investors
   * Back
   * Financial Information
     * Back
     * SEC Filings
     * AMF Regulated Information
     * Annual Reports & General Meetings
     * PFIC Documents
   * Stock Information
   * Investor FAQs
   * Corporate Governance
     * Back
     * Board of Directors
     * Audit Committee
     * Compensation Committee
     * Nominating Committee
 * Careers
 * Contact Us


 * About DBV
   * Leadership Team
 * Our Pipeline
   * Clinical Trials
   * Viaskin™ Peanut
   * Viaskin™ Milk
   * Viaskin™ Milk for EoE
   * Expanded Access Program
 * Our Science
   * Viaskin Platform Technology
   * Scientific Research & Publications
 * News & Resources
   * Press Releases
   * Events & presentations




 * About DBV
   * Leadership Team
 * Our Pipeline
   * Clinical Trials
   * Viaskin™ Peanut
   * Viaskin™ Milk
   * Viaskin™ Milk for EoE
   * Expanded Access Program
 * Our Science
   * Viaskin Platform Technology
   * Scientific Research & Publications
 * News & Resources
   * Press Releases
   * Events & presentations

 * Investors
   * Financial Information
     * SEC Filings
     * AMF Regulated Information
     * Annual Reports & General Meetings
     * PFIC Documents
   * Stock Information
   * Investor FAQs
   * Corporate Governance
     * Board of Directors
     * Audit Committee
     * Compensation Committee
     * Nominating Committee
 * Careers
 * Contact Us




ABOUT DBV


DEDICATED TO IMPROVING THE LIVES OF PATIENTS WITH FOOD ALLERGIES AND OTHER
IMMUNOLOGICAL DISEASES

Learn More


OUR PIPELINE


WE ARE EXPLORING THE BROAD POTENTIAL APPLICATIONS OF THE VIASKIN™ PLATFORM

Learn more



ABOUT DBV


DEDICATED TO IMPROVING THE LIVES OF PATIENTS WITH FOOD ALLERGIES AND OTHER
IMMUNOLOGICAL DISEASES

Learn More


OUR PIPELINE


WE ARE EXPLORING THE BROAD POTENTIAL APPLICATIONS OF THE VIASKIN™ PLATFORM

Learn More








DBV TECHNOLOGIES IS A GLOBAL CLINICAL STAGE BIOPHARMACEUTICAL COMPANY FOUNDED BY
PEDIATRICIANS WHO BELIEVED THAT FOOD ALLERGIES COULD ONE DAY BE TREATED SAFELY
AND EFFECTIVELY.





We are on a journey to advance epicutaneous immunotherapy, using our innovative
technology platform, Viaskin™



We are exploring the first epicutaneous immunotherapy (EPIT™) treatment for
peanut allergy



We plan to explore a potential new class of immunotherapy to transform the lives
of people with unmet medical needs


About DBV



OUR PIPELINE



DBV’s robust development program includes ongoing clinical trials. Viaskin’s
potential to re-educate the immune system makes it a promising approach beyond
food allergies.

View all






VIASKIN™ PEANUT (DBV712)


PEANUT ALLERGY



Comprehensive clinical research program in place, including Phase 3, long-term
studies

Learn more



VIASKIN™ MILK (DBV135)


COW’S MILK ALLERGY



Completed a Phase 1/2 trial to study safety and efficacy in pediatric and
adolescent patients

Learn more



VIASKIN™ MILK (DBV135)


COW’S MILK-INDUCED EOE



Completed a Phase 2a study sponsored by the Children’s Hospital of Philadelphia
(CHOP)

Learn more







OUR SCIENCE

DBV’S APPROACH TO RE-EDUCATING THE IMMUNE SYSTEM

Our novel Viaskin patch is based on investigational EPIT. This potential new
class of immunotherapy is designed to induce an immune response by introducing
minimal amounts of antigen to the skin.


Learn more





FOOD ALLERGIES ARE A GLOBAL HEALTH ISSUE



We are developing the Viaskin technology platform to help improve the lives of
patients diagnosed with peanut and other food allergies.



An estimated 8% of children in the U.S., or approximately 2 children in every
classroom, have a food allergy

Peanut allergy is one of the most common food allergies, and can cause severe,
potentially fatal, allergic reactions, as well as anaphylaxis.

In Europe, about 17 million people are affected by food allergies, including 3.5
million under the age of 25.

Research suggests that only about 20% of people with peanut allergy are expected
to outgrow it during their lifetime

Between 1994 and 2005 Australia experienced a 350% increase in hospital
admissions for food-related anaphylaxis episodes, mostly in children under the
age of five






NEWS & RESOURCES



To stay up to date on DBV news and events, please click here.





DocumentYearTerms

News • 09/21/2022



DBV TECHNOLOGIES PROVIDES CLINICAL UPDATE ON VITESSE PHASE 3 TRIAL

Download PDF



2022

EVENT • 11/03/2022


2022 Q3 FINANCIAL RESULTS

Learn more

PRESENTATION • 08/08/2022


CORPORATE PRESENTATION

Learn more


View All




 * About DBV
 * Our Pipeline
 * Our Science
 * News & Resources
 * Investors
 * Careers
 * Contact Us

 * About DBV
 * Our Pipeline
 * Our Science
 * News & Resources
 * Investors
 * Careers
 * Contact Us

Follow Us


© 2021 DBV Technologies. All rights reserved.
DBV Technologies therapies are investigational and not FDA approved.
 * Terms of Use
 * Privacy Policy
 * Legal Notice
 * Your California Privacy Rights




Our Use of Cookies

Necessary cookies enable the website to function properly. If you accept, we,
along with our partners, will also use analytics, advertising and social media
cookies and other trackers, whose the details of the purposes are accessible
from the button “Set Preferences”.

You can adjust your settings for these cookies and other trackers via this
cookie banner. For more information, please check out our Cookies Policy.

Accept All CookiesRefuse All CookiesSet Preferences
NOTRE UTILISATION DES COOKIES

Nous utilisons des cookies techniques nécessaires au bon fonctionnement du site
internet. Si vous y consentez, nous et nos partenaires utiliserons également des
cookies et autres traceurs de mesure d’audience, de publicité et de réseaux
sociaux, dont le détail des finalités est accessible depuis le bouton « Gérer
les paramètres ».

Vous pouvez paramétrer le dépôt de ces cookies et autres traceurs via ce bandeau
cookies. Pour plus d’informations, veuillez consulter notre politique de gestion
des cookies.

Accept All CookiesRefuse All CookiesSet Preferences
Manage consent
Close

PRIVACY OVERVIEW

This website uses cookies to improve your experience while you navigate through
the website. Out of these cookies, the cookies that are categorized as necessary
are stored on your browser as they are essential for the working of basic
functionalities...
Necessary
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly.
These cookies ensure basic functionalities and security features of the website,
anonymously.

CookieDurationDescriptioncookielawinfo-checkbox-analytics11 monthsThis cookie is
set by GDPR Cookie Consent plugin. The cookie is used to store the user consent
for the cookies in the category "Analytics".cookielawinfo-checkbox-functional11
monthsThe cookie is set by GDPR cookie consent to record the user consent for
the cookies in the category "Functional".cookielawinfo-checkbox-necessary11
monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to
store the user consent for the cookies in the category
"Necessary".cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR
Cookie Consent plugin. The cookie is used to store the user consent for the
cookies in the category "Other.cookielawinfo-checkbox-performance11 monthsThis
cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the
user consent for the cookies in the category
"Performance".viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie
Consent plugin and is used to store whether or not user has consented to the use
of cookies. It does not store any personal data.

Functional
functional
Functional cookies help to perform certain functionalities like sharing the
content of the website on social media platforms, collect feedbacks, and other
third-party features.
Performance
performance
Performance cookies are used to understand and analyze the key performance
indexes of the website which helps in delivering a better user experience for
the visitors.
Analytics
analytics
Analytical cookies are used to understand how visitors interact with the
website. These cookies help provide information on metrics the number of
visitors, bounce rate, traffic source, etc.
Advertisement
advertisement
Advertisement cookies are used to provide visitors with relevant ads and
marketing campaigns. These cookies track visitors across websites and collect
information to provide customized ads.
Others
others
Other uncategorized cookies are those that are being analyzed and have not been
classified into a category as yet.
Save & Accept